Skip to main content

Table 1 Baseline characteristics of the study subjects and their total daily insulin doses

From: Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: A comparative pilot study -Results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study

Subjects (n)

11

Male (%)

9 (81.9)

HbA1c value (%) at CGM

8.4 ± 2.1

Age (years-old)

63.9 ± 7.8

Body mass index (kg/m2)

24.0 ± 4.0

Duration of diabetes (years)

18.0 ± 12.0

Urinary C-peptide (μg/day)

44.3 ± 37.8

Total insulin dose (U/day)

24.9 ± 8.9

Morning insulin dose (U)

13.7 ± 5.2

Evening insulin dose (U)

11.1 ± 4.0

Morning/evening insulin dose ratio

1.24 ± 0.27

  1. Values are represented as mean ± SD or ratio (%).